Form 4: CareDx Director Richard Riggsbee Granted Over 12,000 Restricted Stock Units

CareDx, Inc. Director Richard Bryan Riggsbee was granted 12,103 shares of common stock in the form of restricted stock units, vesting in 2026 or earlier, as part of his compensation.

Summary

• Richard Bryan Riggsbee, a Director of CareDx, Inc. (CDNA), was granted 12,103 shares of common stock on June 13, 2025.
• These shares are in the form of Restricted Stock Units (RSUs) and were acquired at a price of $0.00, indicating a grant rather than a purchase.
• Following this transaction, Mr. Riggsbee beneficially owns 29,517 shares of CareDx common stock directly.
• The RSUs are scheduled to vest in a single installment on the earlier of June 13, 2026, or the day immediately prior to the first annual meeting of stockholders held by CareDx, Inc. after June 13, 2025.

Sentiment

Score: 7

Explanation: The grant of restricted stock units to a director is generally a positive signal, indicating alignment of interests and confidence in the company's future, although it is a routine compensation event rather than a significant new development.

Positives

• The grant of 12,103 Restricted Stock Units (RSUs) to Director Richard Bryan Riggsbee aligns his interests with long-term shareholder value, as the value of these units is tied to the company's stock performance.
• The acquisition of additional shares by a director, even through a grant, can be interpreted as a positive signal regarding management's confidence in the company's future prospects.

Risks

• The value of the granted Restricted Stock Units (RSUs) is subject to market fluctuations of CareDx, Inc. common stock until vesting.
• The vesting of the RSUs is contingent upon Mr. Riggsbee's continued service as a director until the vesting date.

Future Outlook

The 12,103 Restricted Stock Units granted to Director Richard Bryan Riggsbee are set to vest in one installment on the earlier of June 13, 2026, or the day immediately prior to the first annual meeting of stockholders held by CareDx, Inc. after June 13, 2025, indicating a future equity event tied to company performance and continued service.

Industry Context

The grant of Restricted Stock Units (RSUs) to directors is a common practice in the biotechnology and healthcare diagnostics industry, serving as a form of long-term incentive compensation that aligns director interests with shareholder value by tying a portion of their remuneration to the company's stock performance.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of RSUs to a director can be viewed positively as it aligns management's interests with shareholder returns, as the value of the RSUs is directly tied to the company's stock price performance.

Next Steps

• Vesting of the 12,103 Restricted Stock Units on the earlier of June 13, 2026, or the day prior to the first annual meeting of stockholders after June 13, 2025.

Key Dates

Keywords

CareDx, CDNA, Richard Riggsbee, Director, Restricted Stock Units, RSU, SEC Form 4, Insider Transaction, Equity Grant, Compensation, Stock Ownership